Abstract
In the past decade, Chinese vaccine market tripled in scale. China has already
become the world' s largest vaccine producer and now has 28 vaccine companies,
ranking NO.1 around the globe. It can produce one billion person-portions
annually, besides, varieties and quantity also ranks the top in the world.
Output of common vaccine reaches 500 million person-portions such as HBV
vaccine, measles vaccine, etc. Fully planned immunization has been realized.
Compared to developed countries, expenses of China on vaccine and diseases
treatment are relatively low; therefore, China will attach great importance to
vaccine industry development and take it as the key of healthcare and
bio-technology industry. The Development Strategy of China Bio-technology
Industry has rendered the development of secure new types of vaccines as
priority; in the meantime, Chinese government has employed preferential
taxation policy to this industry. In consequence, vaccine industry will become
a high-tech sector with great potential in China bio-technology field. It is
forecasted that China vaccine market scale will approximate RMB8 billion in
2020, with an annual growth rate of 15%, far above world' s level 10%.
Based on authoritative statistics, this report makes in-depth analysis on
China vaccine industry development, vaccine market, vaccine import & export,
key vaccine producers, and also forecasts the development trend of China' s
vaccine industry in 2009. Vaccines involved in this report are Flu Vaccine,
HBV Vaccine, Cerebrospinal Meningitis Vaccine, HIV vaccine, A/HINI vaccine as
well as animal vaccines.
Table of Contents
1. Overview of China Vaccine Market
- 1.1 Impact of Globalization on China Pharmaceutical Market
- 1.1.1 Pharmaceutical Industry Restructuring and International Division
of Labor
- 1.1.2 Accelerated Globalization of Pharmaceutical Market
- 1.1.3 International Status of China Pharmaceutical Industry
- 1.1.4 Forecast of China Status in Global Pharmaceutical Industry, 2009
- 1.2 Strategies for the Access into China Vaccine Market
- 1.2.1 Policy on Foreign Capital Entry into China Vaccine Market
- 1.2.2 Competition Strategies of Chinese Vaccine Companies
- 1.2.3 China Vaccine Market Position in the Global Market
- 1.3 China Biopharmaceutical Sector
- 1.3.1 Sales Revenue, 2008
- 1.3.2 Total production Value, 2008
- 1.3.3 Development Trend, 2009
2. China Vaccine Market Development in 2008-2009
- 2.1 Market Characteristics, 2008
- 2.2 Main Vaccines Types, 2008
- 2.3 Market Structure, 2008
- 2.4 Market Characteristics, 2008
- 2.5 Market Tendency, 2008
- 2.6 Suggestions for Vaccine Industry Development, 2008
3. Markets of Vaccine Varieties, 2008
- 3.1 China Flu Vaccine Market, 2008
- 3.1.1 Market Background
- 3.1.2 Technology R&D
- 3.1.3 Market Size
- 3.1.4 Competition
- 3.1.5 Market Demand
- 3.1.6 Key Producers
- 3.2 China HBV Vaccine Market
- 3.2.1 Market Background
- 3.2.2 Market Size
- 3.2.3 Main Products
- 3.3 China MCV Vaccine Market
- 3.3.1 Market Background
- 3.3.2 Market Size
- 3.4 China AIDS Vaccine Market
- 3.4.1 Market Background
- 3.4.2 Market Size
- 3.4.3 R & D
- 3.5 Other Vaccine Markets and R & D
- 3.5.1 Lung Cancer Vaccine
- 3.5.2 Measles Vaccine
- 3.5.3 Cervical Cancer Vaccine
- 3.5.4 Lupus Erythematosus Vaccine
- 3.5.5 Rotavirus Vaccine
- 3.5.6 Tumor Vaccine
- 3.5.7 A H1N1 Vaccine
4. China Animal Vaccine Market, 2008
- 4.1 Basis of Demand
- 4.1.1 Green Barriers: Promotion of Animal Vaccine
- 4.1.2 Market Background of and Demand for Pet Vaccine
- 4.2 Research Progress in Vaccine for Animal
- 4.2.1 R&D of Animal Virus Vaccine
- 4.2.2 Animal Vaccine R&D Bases in China
- 4.2.3 Successful Development of Purified Rabies Vaccine for Human
- 4.2.4 Research Progress in Pseudorabies Gene-deleted Vaccine
- 4.3 China Bird Flue Vaccine Market
- 4.3.1 Market Background
- 4.3.2 Key Producers
- 4.4 Competition Layout of China Animal Vaccine Market
5. Import and Export of China Vaccine
- 5.1 General Trend of Vaccine Trade
- 5.2 Comparison between Imported Vaccine and Homemade Vaccine
6. China Key Vaccine Producers
- 6.1 China National Biotech Group Co., Ltd
- 6.2 Beijing Tiantan Biological Products Co., Ltd
- 6.3 Shanghai Institute of Biological Products
- 6.4 Shenzhen Kangtai Biological Products Co., Ltd
- 6.5 Changchun Changsheng Life Sciences Co., Ltd
- 6.6 Shenzhen Neptunus Bioengineering Co., Ltd
- 6.7 Guangxi Beisheng Pharmaceutical Co., Ltd
- 6.8 Star Lake Bioscience Co., Ltd
- 6.9 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
- 6.10 Jiangsu Sihuan Bioengineering Co., Ltd
- 6.11 Northeast Pharmaceutical Group Co., Ltd
- 6.12 Chengdu Hoist Group Co., Ltd
- 6.13 Hualan Biological Engineering Inc.
- 6.14 China Animal Husbandry Group
- 6.15 Zhejiang Huahai Pharmaceutical Co., Ltd
7. Impact of SARS on Vaccine Market
- 7.1 Vaccine Market Activated by SARS
- 7.1.1 Booming of Vaccine Industry
- 7.1.2 Bottleneck of Vaccine Industry
- 7.1.3 R&D of SARS Vaccine
- 7.2 Dispute of SARS Patent and Market
- 7.3 Patent Protection Measures on Anti SARS Vaccine
8. Vaccine Market Development Trend and Forecast, 2009
- 8.1 Latest Information on Vaccine R&D
- 8.1.1 Development Trend of New Types of Vaccines
- 8.1.2 New Types of Vaccines
- 8.1.3 R&D of New Types of Vaccines
- 8.1.4 New Types of Combined Vaccines
- 8.2 Forecast of Vaccine Market, 2009
- 8.2.1 Forecast of Global Various Vaccines Markets, 2009
- 8.2.2 Forecast of Animal Vaccine Sector
CHARTS:
- Expenses on Vaccines Proportion to Treatment Cost in China and Developed
Countries
- Sales Value of China Pharmaceutical Industry, Jan-Nov 2008
- Output Value of China Pharmaceutical Industry, Jan-Nov 2008
- China Influenza Virus Vaccine Market Scale, 2007
- Virus Vaccine-Split Influenza Virus Vaccine' s Dosage Form, Price & Origin,
2008
- China HB Vaccine Market Scale, 2007
- Virus Vaccine-Recombinant Vaccine of HB' s (CHO cell)Dosage Form, Price &
Origin, 2008
- Virus Vaccine-Recombinant Vaccine of HB' s (Barm) Dosage Form, Price &
Origin, 2008
- Dosage Form, Price & Origin of Measles Vaccine, 2008
- Dosage Form, Price & Origin of Measles - mumps combined vaccine, 2008
- China Animal Vaccine Market Scale, 2008
- China Animal Vaccine Market Scale, 2005-2009
- Dosage Form, Price & Origin of Oral Rotavirus Vaccine, 2008
- Dosage Form, Price & Origin of Encephalitis B Vaccine, 2008
- Dosage Form, Price & Origin of Rubella Vaccine, 2008
- Dosage Form, Price & Origin of Parotitis Vaccine, 2008
- Dosage Form, Price & Origin of Chickenpox Vaccine, 2008
- Dosage Form, Price & Origin of Freeze-dried Hepatitis A Vaccine, 2008
- Dosage Form, Price & Origin of Renal Hemorrhagic Fever Vaccine, 2008
- Dosage Form, Price & Origin of Rabies Vaccine for Human Being, 2008
- Bird Flu Vaccine Production Capacity of CNADC and Jinyu Baoling
Bio-pharmaceutical Co.
- Key Vaccines Sales of CNADC and Jinyu Baoling Bio-pharmaceutical Co., 2007
- Vaccines Sales of CNADC and Jinyu Baoling Bio-pharmaceutical Co., 2008
- Anti-serum and Vaccine Import Value, 2007 vs. 2008
- Anti-serum and Vaccine Import Value Trend, 2008
- Anti-serum and Vaccine Export Value Trend, 2008
- Anti-serum and Vaccine Import Volume, 2007-2008
- Anti-serum and Vaccine Import Volume Trend, 2008
- Anti-serum and Vaccine Export Volume Trend, 2008
- Anti-serum and Vaccine Export Value, 2007 vs. 2008
- Anti-serum and Vaccine Export Volume, 2007 vs. 2008
- Anti-serum and Vaccine Import Value Trend, 2008-2009
- Anti-serum and Vaccine Import Volume Trend, 2008-2009
- Anti-serum and Vaccine Export Value Trend, 2008-2009
- Anti-serum and Vaccine Export Volume Trend, 2008-2009
- Profitability of Beijing Tiantan Biological Products Co., 2007-2008
- Operation Ability of Beijing Tiantan Biological Products Co., 2007-2008
- Debt-paying Ability of Beijing Tiantan Biological Products Co., 2007-2008
- Capital Structure of Beijing Tiantan Biological Products Co., 2007-2008
- Development Ability of Beijing Tiantan Biological Products Co., 2007-2008
- Cash Flow of Beijing Tiantan Biological Products Co., 2007-2008
- Main Businesses of Beijing Tiantan Biological Products Co. by Sector and
by Product
- Main Businesses of Beijing Tiantan Biological Products Co. by Region
- Structure of Research Institute of Changchun Changsheng Life Sciences Co.
- Profitability of Shenzhen Neptunus Bioengineering Co., 2007-2008
- Operation Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
- Debt-paying Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
- Capital Structure of Shenzhen Neptunus Bioengineering Co., 2007-2008
- Development Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
- Cash Flow of Shenzhen Neptunus Bioengineering Co., 2007-2008
- Main Businesses of Shenzhen Neptunus Bioengineering Co. by Sector and by
Product
- Main Businesses of Shenzhen Neptunus Bioengineering Co. by Region
- Profitability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
- Operation Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
- Debt-paying Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
- Capital Structure of Guangxi Beisheng Pharmaceutical Co., 2007-2008
- Development Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
- Cash Flow of Guangxi Beisheng Pharmaceutical Co., 2007-2008
- Main Businesses of Guangxi Beisheng Pharmaceutical Co. by Sector and by
Product
- Main Businesses of Guangxi Beisheng Pharmaceutical Co. by Region
- Profitability of Star Lake Bioscience Co., 2007-2008
- Operation Ability of Star Lake Bioscience Co., 2007-2008
- Debt-paying Ability of Star Lake Bioscience Co., 2007-2008
- Capital Structure of Star Lake Bioscience Co., 2007-2008
- Development Ability of Star Lake Bioscience Co., 2007-2008
- Cash Flow of Star Lake Bioscience Co., 2007-2008
- Main Businesses of Star Lake Bioscience Co. by Sector and by Product
- Main Businesses of Star Lake Bioscience Co. by Region
- Pharmaceuticals under Research of Shanghai Fosun Pharmaceutical (Group)
Co., 2008
- Profitability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
- Operation Ability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
- Debt-paying Ability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
- Capital Structure of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
- Development Ability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
- Cash Flow of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
- Main Businesses of Shanghai Fosun Pharmaceutical (Group) Co. by Region
- Main Businesses of Shanghai Fosun Pharmaceutical (Group) Co. by Sector
- Main Businesses of Northeast Pharmaceutical Group Co. by Sector in 2008
- Operations of Vaccine and Pharmaceutical Business of Chengdu Hoist Group
Co., 2008
- Main Financial Results of Hualan Biological Engineering Inc., 2008
- Main Business Revenue and Profit Structure of CNADC, 2008
- Sales Statistics of Key Products of CNADC, 2005-2011E
- Sales Statistics of Zhejiang Huahai Pharmaceutical Co., 2006-2008
- Classification of Gene Recombination Vaccines
- Immunoglobulin Vector Vaccine
- Top Three Infectious Diseases in the World and Death Toll
- Vaccines for Respiratory Diseases
- Vaccines for Digestive Diseases
- Vaccines for Insect-borne Infectious Diseases
- Existing Combined Vaccines and Combined Vaccines Under Development
- Pneumococcal Vaccine Market Scale, 2009E
- Hepatitis Vaccines Market Scale, 2009E
- Pediatric Vaccines Market Scale, 2009E
- Adult Vaccines and Influenza Vaccine Market Scale, 2009E
- Therapeutic Vaccines Market Scale, 2009E
|
相關報告
|
